Cite
Genetic Evaluation of A Nation-Wide Dutch Pediatric DCM Cohort: The Use of Genetic Testing in Risk Stratification
MLA
Marijke H. van der Meulen, et al. “Genetic Evaluation of A Nation-Wide Dutch Pediatric DCM Cohort: The Use of Genetic Testing in Risk Stratification.” Circulation. Genomic and Precision Medicine, vol. 15, no. 5, Oct. 2022. EBSCOhost, https://doi.org/10.1161/CIRCGEN.120.002981.
APA
Marijke H. van der Meulen, Johanna C. Herkert, Susanna L. den Boer, Gideon J. du Marchie Sarvaas, Nico Blom, Arend D.J. ten Harkel, Hans M.P.J. Breur, Lukas A.J. Rammeloo, Ronald Tanke, Carlo Marcelis, Ingrid M.B.H. van de Laar, Judith M.A. Verhagen, Ronald H. Lekanne dit Deprez, Daniela Q.C.M. Barge-Schaapveld, Annette Baas, Arjan Sammani, Imke Christiaans, J. Peter van Tintelen, & Michiel Dalinghaus. (2022). Genetic Evaluation of A Nation-Wide Dutch Pediatric DCM Cohort: The Use of Genetic Testing in Risk Stratification. Circulation. Genomic and Precision Medicine, 15(5). https://doi.org/10.1161/CIRCGEN.120.002981
Chicago
Marijke H. van der Meulen, Johanna C. Herkert, Susanna L. den Boer, Gideon J. du Marchie Sarvaas, Nico Blom, Arend D.J. ten Harkel, Hans M.P.J. Breur, et al. 2022. “Genetic Evaluation of A Nation-Wide Dutch Pediatric DCM Cohort: The Use of Genetic Testing in Risk Stratification.” Circulation. Genomic and Precision Medicine 15 (5). doi:10.1161/CIRCGEN.120.002981.